Validity of self-reported antiretroviral therapy use among injection drug users [1]

Journal of Acquired Immune Deficiency Syndromes

Volumn 41, Issue 4, 2006, Pages 530-531

  Wood, Evan ^a,b   Kerr, Thomas ^a   Hogg, Robert S ^a   Zhang, Ruth ^a   Tyndall, Mark W ^a,b   Montaner, Julio S G ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LETTER; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SYRINGE;

ANTI-HIV AGENTS; COHORT STUDIES; DATA COLLECTION; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; REPRODUCIBILITY OF RESULTS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33646796018     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000199096.11215.79     Document Type: Letter

References (10)

1. Wood E, Montaner JS, Schechter MT, et al. Prevalence and correlates of untreated HIV-1 infection in the era of modern antiretroviral therapy. J Infect Dis. 2003;188:1164-1170.
2. Hogg RS, Weber AE, Craib KJ, et al. One world, one hope: the cost of providing antiretroviral therapy to all nations. AIDS. 1998; 12:2203-2209.
3. Wood E, Hogg RS, Bonner S, et al. Staging for antiretroviral therapy among HIV-infected drug users. JAMA. 2004;292:1175-1177.
4. Celentano DD, Vlahov D, Cohn S, et al. Self-reported antiretroviral therapy in injection drug users. JAMA. 1998;280:544-546.
5. Haubrich RH, Little SJ, Currier JS, et al. The value of patient-reported adherence to anti-retroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS. 1999;13:1099-1107.
6. Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999;353:1657-1661.
7. Safaeian M, Brookmeyer R, Vlahov D, et al. Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation. Am J Epidemiol. 2002;155:169-175.
8. Wood E, Kerr T, Buchner C, et al. Methodology for evaluating insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduction Journal. 2004;1:9.
9. Strathdee SA, Palepu A, Cornelisse PG, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998;280:547-549.
10. Gifford AL, Bormann JE, Shively MJ, et al. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23:386-395.